McKesson agrees to buy Precision Medicine Group for $2.25 billion
Reuters2026/08/25 12:03- McKesson agreed to buy Precision Medicine Group for about USD 2.25 billion.
- Business will sit in McKesson’s Oncology & Multispecialty segment once the deal closes.
- Transaction aims to expand clinical research and biopharma commercialization services, including stronger clinical trial execution.
- Precision Medicine Group provides clinical research and commercialization services to biopharma clients.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
EdiliziAcrobatica announces shareholder meeting notice

Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.